Hypoglycemic and hypocholesterolemic effects of Coptis chinensis franch inflorescence

被引:84
作者
Yuan, Lujiang [1 ]
Tu, Dawei
Ye, Xiaoli
Wu, Jianping
机构
[1] SW Univ, Chem Inst Pharmaceut Resource, Chongqing 400716, Peoples R China
[2] SW Univ, Sch Life Sci, Chongqing 400715, Peoples R China
[3] Univ Manitoba, Dept Human Nutr Sci, Winnipeg, MB R3T 2N2, Canada
关键词
blood sugar; Coptis chinensis franch inflorescence; hypercholesterolemia; hyperglycemia; LDL;
D O I
10.1007/s11130-006-0023-7
中图分类号
Q94 [植物学];
学科分类号
071001 [植物学];
摘要
Hypocholesterolemic and hypoglycemic activities of Coptis chinensis franch inflorescence (Coptis inflorescence) were studied using animal models. Serum total and LDL cholesterol of rats fed a diet containing 1% cholesterol and 0.5% cholic acid increased, as compared with those of rats fed a normal diet. The level of total and LDL cholesterol were reduced markedly in a dose dependent manner, in rats given Coptis inflorescence extract orally at doses of 0.25, 0.5 g/kg.day for 4 weeks. In diabetic rats induced by alloxan, Coptis inflorescence extract showed a significant (p < 0.05) blood sugar lowering activity at all experimented doses (0.125, 0.25 and 0.5 g/kg.day). The highest reduction of blood sugar was about 58% when the rats were given Coptis inflorescence extract orally at a dose of 0.5 g/kg.day for 3 weeks. The 100 g dried water extract of Coptis inflorescence contained 8.11 g total alkaloid, 3.34 g berberin, 1.08 g palmatine and 0.66 g jatrorrhizine, which had long been identified as active compounds in Coptis chinensis franch root (Coptis root). Thus, the results suggest that Coptis inflorescence would be effective in the prevention and management of coronary artery disease by lowering serum cholesterol and blood sugar.
引用
收藏
页码:139 / 144
页数:6
相关论文
共 30 条
[1]
AKHTER MH, 1977, INDIAN J MED RES, V65, P133
[2]
BERBERINE SULFATE - ANTIMICROBIAL ACTIVITY, BIOASSAY, AND MODE OF ACTION [J].
AMIN, AH ;
SUBBAIAH, TV ;
ABBASI, KM .
CANADIAN JOURNAL OF MICROBIOLOGY, 1969, 15 (09) :1067-&
[3]
Anis K. V., 1999, Pharmacy and Pharmacology Communications, V5, P697
[4]
Anturlikar S. D., 1995, Indian Journal of Physiology and Pharmacology, V39, P95
[5]
ATHEROSCLEROSIS - BASIC MECHANISMS - OXIDATION, INFLAMMATION, AND GENETICS [J].
BERLINER, JA ;
NAVAB, M ;
FOGELMAN, AM ;
FRANK, JS ;
DEMER, LL ;
EDWARDS, PA ;
WATSON, AD ;
LUSIS, AJ .
CIRCULATION, 1995, 91 (09) :2488-2496
[6]
BOVA S, 1992, J PHARMACOL EXP THER, V261, P318
[7]
INCIDENCE OF CORONARY HEART-DISEASE AND LIPOPROTEIN CHOLESTEROL LEVELS - THE FRAMINGHAM-STUDY [J].
CASTELLI, WP ;
GARRISON, RJ ;
WILSON, PWF ;
ABBOTT, RD ;
KALOUSDIAN, S ;
KANNEL, WB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20) :2835-2838
[8]
A comparative evaluation of some blood sugar lowering agents of plant origin [J].
Chattopadhyay, RR .
JOURNAL OF ETHNOPHARMACOLOGY, 1999, 67 (03) :367-372
[9]
Bioactive components in rice bran oil improve lipid profiles in rats fed a high-cholesterol diet [J].
Ha, TY ;
Han, S ;
Kim, SR ;
Kim, IH ;
Lee, HY ;
Kim, HK .
NUTRITION RESEARCH, 2005, 25 (06) :597-606
[10]
Hong H., 2001, J ANHUI TCM COLL, V20, P59